Hormone therapy: The Women's Health Initiative has caused confusion and concern

Fertility and Sterility

Volumn 80, Issue 3, 2003, Pages 491-493

  Reid, Robert L ^a  

^a KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFUSION; FEMALE; GENERAL PRACTITIONER; GYNECOLOGY; HEALTH; HEART PROTECTION; HORMONAL THERAPY; HUMAN; MENOPAUSAL SYNDROME; NARCISSISM; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; SHORT SURVEY; TREATMENT CONTRAINDICATION;

EID: 0042733270     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00993-2     Document Type: Note

References (17)

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333.
2. Reid R.L. Translating the latest scientific advances into clinical practice. JOGC. 24:2002;771-774.
3. Sackett D.L. The arrogance of preventive medicine. CMAJ. 167:2002;363-364.
4. Rosenberg L., Hennekens C.H., Rosner B., Belanger C., Rothman K.J., Speizer F.E. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 139:1981;47-51.
5. Grodstein F., Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis. 38:1995;199-210.
6. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 340:1999;1801-1811.
7. Nabulsi A.A., Folsom A.R., White A., Patsch W., Heiss G., Wak K., et al. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 328:1993;1069-1075.
8. Gruchow H.W., Anderson A.J., Barboriak J.J., Sobocinski K.A. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J. 115:1988;954-963.
9. Sullivan J.M., Vander Zwaag R., Hughes J.P., Maddock V., Kroetz F.W., Ramanathan K.B., et al. Estrogen replacement and coronary artery disease. Arch Intern Med. 150:1990;2557-2562.
10. Rosano G.M., Sarrel P.M., Poole-Wilson P.A., Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 342:1993;133-136.
11. Col N.F., Eckman M.H., Karas R.H., Pauker S.G., Goldberg R.J., Ross E.M., et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA. 277:1997;1140-1147.
12. Wild R.A., Taylor E.L., Knehans A. The gynecologist and the prevention of cardiovascular disease. AJOG. 172:1995;1-13.
13. Grodstein F., Manson J.E., Colditz G.A., Willett W.C., Speizer F.E., Stampfer M.J. A prospective observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 133:2000;933-941.
14. Collins P. Vascular effects of hormones. Maturitas. 38:2001;45-50.
15. Strickler R.C. Women's Health Initiative results a glass more empty than full. Fertil Steril. 80:2003;488-490.
16. de Ziegler D., Meldrum D.R. From in vitro fertilization (IVF) to menopause physiologic hormone replacement adapted from donor egg IVF may be our best option for hormone therapy. Fertil Steril. 80:2003;485-487.
17. Strong J.P., Malcolm G.T., McMahan C.A., Tracy R.E., Newman W.P. III, Herderick E.E., et al. Prevalence and extent of atherosclerosis in adolescents and young adults implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 281:1999;727-735.